- Home
- Publications
- Publication Search
- Publication Details
Title
Presence and role of stem cells in ovarian cancer
Authors
Keywords
-
Journal
World Journal of Stem Cells
Volume 11, Issue 7, Pages 383-397
Publisher
Baishideng Publishing Group Inc.
Online
2019-07-25
DOI
10.4252/wjsc.v11.i7.383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of hysterectomy with simultaneous bilateral salpingectomy on the subsequent pelvic mass
- (2019) Xiaopei Chao et al. Journal of Ovarian Research
- TERT promoter mutation in adult granulosa cell tumor of the ovary
- (2018) Jessica A. Pilsworth et al. MODERN PATHOLOGY
- Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data
- (2018) Tianyu Zhang et al. PLoS One
- ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3
- (2018) Yichen Wang et al. OncoTargets and Therapy
- Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
- (2018) Seema C. Parte et al. Journal of Ovarian Research
- Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
- (2018) Lynn Roy et al. Cancers
- Ovarian cancer stem cells and their role in drug resistance
- (2018) Zalitha Pieterse et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- OCT4 accelerates tumorigenesis through activating JAK/STAT signaling in ovarian cancer side population cells
- (2018) Zhengyi Ruan et al. Cancer Management and Research
- Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor–Based Immunotherapy and Chemotherapy
- (2017) Rüdiger Klapdor et al. HUMAN GENE THERAPY
- Cancer Stem Cell–Related Marker NANOG Expression in Ovarian Serous Tumors
- (2017) Nataša Kenda Šuster et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
- (2017) Xiaoduan Li et al. Molecular Cancer
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
- (2017) Davide Pradella et al. Molecular Cancer
- Ovarian cancer stem cells: still an elusive entity?
- (2017) Michela Lupia et al. Molecular Cancer
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- Tumour–adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles
- (2017) Lucía Robado de Lope et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Ovarian cancer stem cells more questions than answers
- (2017) Petronella Beatrix Ottevanger SEMINARS IN CANCER BIOLOGY
- Ovarian Cancer Stem Cells: Unraveling a Germline Connection
- (2017) Seema C. Parte et al. STEM CELLS AND DEVELOPMENT
- A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
- (2017) Lin Cheng et al. Journal of Ovarian Research
- Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers
- (2017) Natasa Kenda Suster et al. Journal of Ovarian Research
- Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc
- (2017) Ying-Xia Ning et al. Oncotarget
- The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer
- (2017) Shingo Tayama et al. Oncotarget
- Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer effectively inhibits intraperitoneal ovarian cancer growth
- (2017) Jingying Zheng et al. Theranostics
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche
- (2016) Maximilian Boesch et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
- (2016) Shan Qin et al. BIOSCIENCE REPORTS
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- To wake up cancer stem cells, or to let them sleep, that is the question
- (2016) Shoichiro Takeishi et al. CANCER SCIENCE
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
- (2016) Radosſaw Januchowski et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells
- (2016) Koji Nakamura et al. MOLECULAR CANCER RESEARCH
- Epithelial–mesenchymal transition: a new target in anticancer drug discovery
- (2016) Fabrizio Marcucci et al. NATURE REVIEWS DRUG DISCOVERY
- NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer
- (2016) Suqing Liu et al. TUMOR BIOLOGY
- Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer
- (2016) Irma Virant-Klun et al. Journal of Ovarian Research
- Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro
- (2016) Soochi Kim et al. Oncotarget
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer
- (2016) Irma Virant-Klun et al. Scientific Reports
- The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
- (2015) Ben Davidson et al. HUMAN PATHOLOGY
- Epithelial ovarian cancer with CD117 phenotype is highly aggressive and resistant to chemotherapy
- (2015) Irena Conic et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78
- (2015) L. Mo et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
- (2015) Xin Ye et al. TRENDS IN CELL BIOLOGY
- Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
- (2015) Yan Gao et al. Oncotarget
- Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
- (2015) Mohit Kumar Jolly Frontiers in Oncology
- Advances in tumor markers of ovarian cancer for early diagnosis
- (2015) W Zhang et al. INDIAN JOURNAL OF CANCER
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
- (2014) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
- (2014) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Estrogen-Related Receptor Alpha Inhibits Epithelial-to-Mesenchymal Transition and Stem Cell Properties of Ovarian Cancer Cells
- (2014) Sophia SN Lam et al. MOLECULAR THERAPY
- Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening
- (2014) YUTING HUANG et al. ONCOLOGY REPORTS
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of the mechanism of epithelial-mesenchymal transition in human ovarian cancer stem cells transfected with a WW domain-containing oxidoreductase gene
- (2014) HONGCHAO YAN et al. Oncology Letters
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- Crosstalk of Oncogenic Signaling Pathways during Epithelial–Mesenchymal Transition
- (2014) Stephan Lindsey et al. Frontiers in Oncology
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
- (2013) Tuan Zea Tan et al. EMBO Molecular Medicine
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis
- (2013) Jing Zhang et al. HUMAN PATHOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Unknown
- (2013) Hua Jiang et al. MOLECULAR MEDICINE
- Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations
- (2013) Sagi Abelson et al. PLoS One
- The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
- (2013) Jiabo Di et al. CELLULAR ONCOLOGY
- Small SSEA-4-positive cells from human ovarian cell cultures: related to embryonic stem cells and germinal lineage?
- (2013) Irma Virant-Klun et al. Journal of Ovarian Research
- Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian Cancer
- (2013) Wei Zhang et al. Cell Reports
- Expression of Pluripotency and Oocyte-Related Genes in Single Putative Stem Cells from Human Adult Ovarian Surface Epithelium CulturedIn Vitroin the Presence of Follicular Fluid
- (2013) Irma Virant-Klun et al. Biomed Research International
- Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
- (2013) Qinglei Zhan et al. Biomed Research International
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- On the connections between cancer stem cells and EMT
- (2012) Mario Cioce et al. CELL CYCLE
- Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
- (2012) Appalaraju Jaggupilli et al. Clinical & Developmental Immunology
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Prognostic Impact of the Cancer Stem Cell–Related Marker NANOG in Ovarian Serous Carcinoma
- (2012) Maria Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
- (2012) M K Y Siu et al. ONCOGENE
- Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
- (2012) Ardian Latifi et al. PLoS One
- Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
- (2012) K. Meirelles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin
- (2011) Francesca Casagrande et al. CANCER
- Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line
- (2011) Jun Dou et al. CELL BIOLOGY INTERNATIONAL
- Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer
- (2011) Nicole Vincent Jordan et al. CELL CYCLE
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin
- (2011) Yoichi Kobayashi et al. GYNECOLOGIC ONCOLOGY
- CD133 expression associated with poor prognosis in ovarian cancer
- (2011) Jing Zhang et al. MODERN PATHOLOGY
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Nanog Is Highly Expressed in Ovarian Serous Cystadenocarcinoma and Correlated with Clinical Stage and Pathological Grade
- (2011) Yongmiao Pan et al. PATHOBIOLOGY
- Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
- (2011) Åslaug Helland et al. PLoS One
- Detection, Characterization, and Spontaneous Differentiation In Vitro of Very Small Embryonic-Like Putative Stem Cells in Adult Mammalian Ovary
- (2011) Seema Parte et al. STEM CELLS AND DEVELOPMENT
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Targeting CD24 for treatment of ovarian cancer by short hairpin RNA
- (2009) Dan Su et al. CYTOTHERAPY
- Pathogenesis of Ovarian Cancer
- (2009) Robert J. Kurman et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
- (2009) Bin-Bing S. Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
- (2009) Michael D. Curley et al. STEM CELLS
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes
- (2008) Irma Virant-Klun et al. DIFFERENTIATION
- Very small embryonic-like stem cells: Characterization, developmental origin, and biological significance
- (2008) Mariusz Z. Ratajczak et al. EXPERIMENTAL HEMATOLOGY
- Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
- (2008) Russell J. Schilder et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started